Thaler S - Search Results

1

Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo.

Huber C, Bobek N, Kuball J, Thaler S, Hoffarth S, Huber C, Theobald M, Schuler M. Huber C, et al. Among authors: thaler s. Cell Death Differ. 2005 Apr;12(4):317-25. doi: 10.1038/sj.cdd.4401563. Cell Death Differ. 2005. PMID: 15678149

2

An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.

Marques CA, Hähnel PS, Wölfel C, Thaler S, Huber C, Theobald M, Schuler M. Marques CA, et al. Among authors: thaler s. Blood. 2008 Feb 1;111(3):1413-9. doi: 10.1182/blood-2007-05-089458. Epub 2007 Oct 30. Blood. 2008. PMID: 17971488 Free article.

3

Targeting AKT signaling sensitizes cancer to cellular immunotherapy.

Hähnel PS, Thaler S, Antunes E, Huber C, Theobald M, Schuler M. Hähnel PS, et al. Among authors: thaler s. Cancer Res. 2008 May 15;68(10):3899-906. doi: 10.1158/0008-5472.CAN-07-6286. Cancer Res. 2008. PMID: 18483275

4

RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.

Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M. Thaler S, et al. Cancer Res. 2009 Mar 1;69(5):1748-57. doi: 10.1158/0008-5472.CAN-08-1377. Epub 2009 Feb 17. Cancer Res. 2009. PMID: 19223555

5

The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.

Thaler S, Thiede G, Hengstler JG, Schad A, Schmidt M, Sleeman JP. Thaler S, et al. Int J Cancer. 2015 Aug 1;137(3):686-97. doi: 10.1002/ijc.29404. Epub 2015 Jan 8. Int J Cancer. 2015. PMID: 25530422 Free article.

6

Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes.

Cotarelo CL, Schad A, Kirkpatrick CJ, Sleeman JP, Springer E, Schmidt M, Thaler S. Cotarelo CL, et al. Among authors: thaler s. Oncotarget. 2016 Nov 15;7(46):74846-74859. doi: 10.18632/oncotarget.12432. Oncotarget. 2016. PMID: 27713152 Free PMC article.

7

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP. Thaler S, et al. Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266866

8

Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.

Cotarelo CL, Zschöck-Manus A, Schmidt M, Schad A, Brochhausen C, Kirkpatrick CJ, Thaler S. Cotarelo CL, et al. Among authors: thaler s. Clin Exp Metastasis. 2021 Feb;38(1):61-72. doi: 10.1007/s10585-020-10065-9. Epub 2020 Nov 29. Clin Exp Metastasis. 2021. PMID: 33249518 Free PMC article.

9

Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.

Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman JP. Thaler S, et al. Oncotarget. 2017 Aug 14;8(42):72281-72301. doi: 10.18632/oncotarget.20261. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069787 Free PMC article.

10

Spatiotemporally controlled induction of gene expression in vivo allows tracking the fate of tumor cells that traffic through the lymphatics.

Grau N, Scherer SD, Rothley M, Roßwag S, Thiele W, Stoecklein NH, Cremers N, Thaler S, Garvalov BK, Sleeman JP. Grau N, et al. Among authors: thaler s. Int J Cancer. 2020 Aug 15;147(4):1190-1198. doi: 10.1002/ijc.32766. Epub 2019 Nov 21. Int J Cancer. 2020. PMID: 31675122 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page